A mighty antibody is the bane of multiple coronaviruses

  • 📰 Nature
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 68%

United States Headlines News

Potent immune molecule could be used to treat COVID-19 and infections caused by viruses related to SARS-CoV-2.

Particles of SARS-CoV-2 bud from a cell. The virus and related pathogens are inhibited by an antibody culled from a person who had COVID-19. Credit: Steve Gschmeissner/Science Photo Library

A newly isolated antibody that blocks SARS-CoV-2 from infecting cells could one day be used to treat infections caused by current and future variants of the virus that causes COVID-19, and even infections from related virusesDavid Veesler and his colleagues at the University of Washington, Seattle, searched the blood of an infected person for antibodies that bind the SARS-CoV-2 spike protein, which lets the virus enter human cells.

S2K146 also binds spike protein from the two related viruses: SARS-CoV, which caused an outbreak of respiratory disease in 2002–2003, and WIV-1, which infects bats and has the potential to infect humans. Administering S2K146 to hamsters infected with SARS-CoV-2 greatly reduced or eliminated viral replication.

The team found that mutations that prevented S2K146 from binding to spike protein also rendered SARS-CoV-2 much less effective at infecting cells. This suggests that the virus is unlikely to mutate its way out of S2K146’s grasp.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Trump supporters are the worst antibodies.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 64. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Covid-19 news: Ministers plan for UK to ‘live with covid’Today’s covid-19 news: · UK ministers plan for nation to ‘live with covid’ · Novak Djokovic released from detention, but may have Australia visa cancelled · Mixed signals as to whether free lateral flow tests will be phased out in England
Source: newscientist - 🏆 541. / 51 Read more »

COVID-19 long hauler from Hobart describes life after virus: ‘I had more symptoms post-COVID than I did during the time I had the COVID’Since her hospital stay, Camarena said she still feels the symptoms of COVID-19 most days, mostly chronic fatigue and brain fog. Now, Camarena said she has to pick between working out or taking the dog on a walk because she can no longer do both in a single day. bUt sHe dIdN’T dIE My neighbor FORMER 👮 contracted Covid at work, one year later still isn't breathing correctly, can barely care for self, loses balance, sleeps ALL THE TIME. Quality of life is negative. Covid is nothing to play with. I ran to get my vaccine right away! More lies.
Source: chicagotribune - 🏆 8. / 91 Read more »

Balancing COVID-19 health precautions for childrenDr. Grace Lee, pediatric infectious diseases physician at Stanford Children's Health, says we have to learn to live with COVID, but in a safe way. Transmission at schools are not as common as within the community, she says. Finally, getting kids vaccinated adds an important layer of protection to keep kids safe and to prevent the spread of the disease.
Source: KTVU - 🏆 465. / 53 Read more »

Marin schools shuffle staff to cover COVID-19 teacher quarantinesKeeping schools open remains “top priority” for county public health and education teams as 3.6% of returned tests for students, staffers come back positive for coronavirus. Translation; fake sick out
Source: mercnews - 🏆 88. / 68 Read more »

Avacta pauses sales of COVID-19 antigen test to boost Omicron sensitivityBritish biotech firm Avacta Group said on Monday it was halting sales of its COVID-19 antigen lateral flow test, AffiDX, to replace antibodies in the device and boost its ability to detect the Omicron coronavirus variant at lower viral loads.
Source: Reuters - 🏆 2. / 97 Read more »

Novartis to seek FDA approval for COVID-19 treatment after positive dataNovartis AG and Molecular Partners AG on Monday reported positive topline data from their antiviral Covid-19 treatment ensovibep, and will seek expedited...
Source: MarketWatch - 🏆 3. / 97 Read more »